Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01789229

Establishment of a Tumor Bank for Tissue Samples

Establishment of a tumor bank, consisting of tissue samples of tumor patients (benign and malign tumors) and healthy people as controls. The tissue samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tissue tumor bank.

This tumor bank for tissue samples, together with our tumorbank for blood samples (NCT01763125) combined constitute the entity "Tumorbank".

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Ovarian Neoplasms Adnexal Diseases Breast Diseases Breast Neoplasms Colonic Diseases Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Endocrine Gland Neoplasms Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Gastrointestinal Diseases Gastrointestinal Neoplasms Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Gonadal Disorders Intestinal Diseases Intestinal Neoplasms Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Neoplasms of the Female Genitalia Ovarian Diseases Rectal Diseases Respiratory Tract Diseases Respiratory Tract Neoplasms Skin Diseases Skin and Connective Tissue Diseases Thoracic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University Vienna, Dptm. of Obstetrics & Gynaecology, Vienna, Austria

Loading trial locations.

About this study

Recent progress in diagnosis and therapy of cancer diseases can be ascribed mainly to translational research. The relevance of "translational oncology" will only increase in the future -"From bench to bedside" - the swift implementation of new science research results in clinical studies in order to expedite progress in clinical cancer therapy for the benefit of the patient.

Its almost a matter of course in the medical science today to collect biological samples together with clinical information thereby creating the foundation for future excellent fundamental research.

The aim of this tumor bank is to consist of biological samples (together with a blood bank - see NCT01763125) and isolates of tumor patients and healthy people as controls. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank. The content of the tumor bank can provide essential material for current and future research (e.g. analyses of prognostic or predictive tumor markers; genetically analysis (polymorphism, mutation, hypermethylation; verification and characterisation of disseminated tumor cells).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male/Female
  • Age 18 to 90 years max.
  • Just one current known malignant disease or just one current inflammatory disease

Exclusion criteria

  • Inflammatory disease and malignant disease
  • multiple malignancies
  • multiple diseases
  • underage

Treatment and study plan

Tumor tissue collection

Other

Tissue sample is collected during therapeutic intervention by a medical doctor/surgeon.

Frozen tissue sections are first transferred to Dept.of Pathology. Pathologist samples required tissue to obtain enough evidence for analysis/diagnosis.

Rest tumor material with or without malignant cells is tranferred to the lab for Molecular Oncology of Prof.Zeillinger.

Sampling of ascites and pleural effusion

Other

Samples of malignant ascites and/or malignant pleural effusion is only collected during therapeutic intervention from patients at inpatient care.

Collecting urine samples

Other

Patient is asked to give a urine sample. Urine is collected in urine beaker.

Collecting saliva sample

Other

Saliva sample is collected by spatula from the mouth cavity of the patient.

Collecting sputum

Other

Patient is asked to produce sputum into a 50ml lab tube.

Collecting stool samples

Other

Stool samples are collected prior to bowel preparation for colonoscopy. Device for sampling is provided to the patient.

Lavage/Irrigation

Other

Irrigation liquid is collected during routine therapeutic or diagnostic procedure, e.g. lavage of the uterine cavity and fallopian tubes of women scheduled for surgery.

Primary outcomes

  1. Establishment of blood/tissue bank consisting of oncological samples from cancer patients and benign and healthy controls.

    Time frame: 14 years

Study contacts

Contact information is provided by the study sponsor or research team.

Eva Obermayr, PhD

CONTACT

[email protected]

+4340400 ext. 78270

Robert Zeillinger, Prof.Dr.

CONTACT

[email protected]

+43140400 ext. 78310

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Establishment of a Tissue Sample Bank in the Field of Gynaecological Oncology

Important dates

Study start
2003
Primary completion
2026
Study completion
2026
First posted
Feb 12, 2013
Registry last updated
Mar 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.